Skip to main
CVSA

CVSA Stock Forecast & Price Target

CVSA Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Covista is a leading educator of healthcare professionals, with a diversified portfolio of online and campus-based universities. Despite potential risks from political headwinds and the new loan caps, Covista's strong mix of healthcare-focused programs and favorable supply/demand dynamics make it a top performer in the sector with attractive financials and a solid growth outlook. Although concerns around AI-driven student acquisition and competition from other peers are worth monitoring, Covista's exposure to the growing healthcare field positions it as a more defensive stock for investors seeking long-term stability.

Bears say

Covista is facing a challenging industry backdrop and may struggle to maintain its revenue and EBITDA growth in the near-term. The company's exposure to the GenAI debate in student acquisition may also hinder its potential for multiple expansion. While its revenue and EBITDA projections for FY27 are optimistic, the company's increased CapEx and dilutive margin projections for the near future may limit its profitability. Its recent enrollment growth, particularly in the Chamberlain division, may provide a slight boost to sentiment, but may not be sustainable in the long-term.

CVSA has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Adtalem Global Education Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Adtalem Global Education Inc (CVSA) Forecast

Analysts have given CVSA a Hold based on their latest research and market trends.

According to 2 analysts, CVSA has a Hold consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $155, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $155, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Adtalem Global Education Inc (CVSA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.